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Research
AbstrACt
Objective This observational study critically explored 
the performance of different predictive risk models 
simulating three data access scenarios, comparing: (1) 
sociodemographic and clinical profiles; (2) consistency in 
high-risk designation across models; and (3) persistence 
of high-risk status over time.
Methods Cross-sectional health survey data (2006–2009) 
for more than 260 000 Australian adults 45+ years 
were linked to longitudinal individual hospital, primary 
care, pharmacy and mortality data. Three risk models 
predicting acute emergency hospitalisations were 
explored, simulating conditions where data are accessed 
through primary care practice management systems, or 
through hospital-based electronic records, or through a 
hypothetical ‘full’ model using a wider array of linked data. 
High-risk patients were identified using different risk score 
thresholds. Models were reapplied monthly for 24 months 
to assess persistence in high-risk categorisation.
results The three models displayed similar statistical 
performance. Three-quarters of patients in the high-risk 
quintile from the ‘full’ model were also identified using the 
primary care or hospital-based models, with the remaining 
patients differing according to age, frailty, multimorbidity, 
self-rated health, polypharmacy, prior hospitalisations 
and imminent mortality. The use of higher risk prediction 
thresholds resulted in lower levels of agreement in high-
risk designation across models and greater morbidity and 
mortality in identified patient populations. Persistence of 
high-risk status varied across approaches according to 
updated information on utilisation history, with up to 25% 
of patients reassessed as lower risk within 1 year.
Conclusion/implications Small differences in risk 
predictors or risk thresholds resulted in comparatively 
large differences in who was classified as high risk 
and for how long. Pragmatic predictive risk modelling 
design decisions based on data availability or projected 
high-risk patient numbers may therefore influence 
individuals identified as high-risk, overall case mix and risk 
persistence. Routine data linkage would enable greater 
flexibility in developing and optimising predictive risk 
models appropriate to both case-finding and performance 
measurement applications.
IntrOduCtIOn 
To address population health objectives and 
expenditure growth associated with ageing 
populations and increased chronic disease 
prevalence, governments and health systems 
in the UK, Australia, the USA and elsewhere 
are exploring the use of predictive risk 
modelling (PRM) to better target and inte-
grate services.1–5 PRM algorithms calculate 
the probability that a specific patient will 
experience a future event, such as hospitalisa-
tion, based on their unique risk profile. Two 
different but related applications include 
identifying individual patients for interven-
tion (‘case-finding’) and creating high-risk 
population segments for focused healthcare 
performance analysis.
Internationally, considerable variability 
exists in PRM implementations due to 
differences in health system organisation 
and financing, which affects perceptions of 
accountability and data access. The entity 
responsible to administer PRM can be hotly 
debated, as exemplified by the UK’s shift 
from a centrally administered algorithm to 
practice-specific adaptations.6 PRM requires 
strengths and limitations of this study
 ► This simulation illustrates the extent to which 
predictive risk models (PRMs) that rely on different 
data or models specifications will appraise patient 
risk status differently.
 ► Linked population and service use data facilitated 
simulation of several ‘real world’ PRM case-finding 
and performance measurement applications.
 ► Simulation findings are intended to be broadly 
illustrative, not generalisable.
 ► In practice, case  mix, risk persistence and high-
risk group agreement across alternative PRM 
applications could differ due to differences in 
risk factor availability or measurement, base 
populations, prediction periods and other modelling 
specifications.
 ► The study population is not representative of New 
South Wales due to oversampling of elderly and rural 
residents and a low survey response rate (18%) 
limit.
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access to detailed, patient-level risk factor and health 
service information, ideally, across clinical and commu-
nity settings and over time. However, for many coun-
tries, data are non-linked or partially linked. Although 
important to intervention design, limited comparative 
information exists regarding high-risk patient character-
istics identified in different data environments.7
A number of review studies compare alternative PRMs 
with focus on predictive statistics rather than resultant 
patient profiles and risk persistence8–12 Validation studies 
of specific instruments also focus on statistical perfor-
mance, with some also estimating future per-person 
spending of identified high-risk patients13–16 Billings 
et al’s study17 is one of the few studies to quantify gains 
in prediction performance of a hospital-oriented PRM 
through sequential addition of emergency, outpa-
tient and general practice (GP) information. They also 
observe that PRMs using non-hospital data identified 
more lower acuity patients which could present earlier 
intervention opportunities.17 Two studies have found that 
high-risk population subgroups differ according to the 
persistence of high-risk status over time.18 19
Australia’s planned use of PRM in state and national 
trials provides an opportunity to examine patient profiles 
under different data access scenarios. For example, the 
Commonwealth’s health care homes initiative will employ 
an automated PRM using GP data to identify primary 
care patients who are at risk of hospitalisation and 
assess them for allied health service needs and develop 
multidisciplinary care plans.20 In parallel, New South 
Wales (NSW) Health will implement an integrated care 
initiative that will use a hospital algorithm to identify 
recently discharged patients who need similar supports.21 
Both programmes will require that GPs use a stan-
dardised care clinical screening tool to determine eligi-
bility for specific services. Despite patient identification 
efforts that rely on different PRMs using different combi-
nations of GP data, hospital data and patient survey data, 
both programmes focus on enhanced outpatient care 
provision to high-risk patients. The likelihood of patient 
overlap in separately administered high-risk patient iden-
tification efforts is unknown.
This research critically explored the comparative 
patient identification performance of different PRM algo-
rithms, simulating three common data access scenarios: 
a ‘full’ model using all available information, a primary 
care data only (‘GP’) model and a hospital data only 
(‘hospital’) model. Using models that draw elements 
from planned Australian PRMs and patient assessment 
tools, we assessed: (1) sociodemographic and clinical 
profiles; (2) consistency in high-risk designation across 
models; and (3) persistence of high-risk status.
MethOds
data sources
The PRMs used population survey and linked health 
administrative data for participants in the 45 and Up 
















  Age, gender, Aboriginal status, geographic remoteness, SES, marital 
status
X X X X
  Language spoken at home X X – X
  Income, social isolation X – – 
Health status and health behaviours
  Health condition count X X X X
  Self-rated health, polypharmacy, anxiety/depression, BMI, smoking 
status, unsafe alcohol use
X X – X
  Functional status, falls X – – 
Prior health service utilisation
  Previous hospitalisations, admission via ED, length of stay of previous 
hospitalisation, previous ED use
X – X – 
Primary care accessibility
  GP use X – – X
Total number of variables 23 14 11 15
The survey variables ‘health condition count’ and ‘self-rated health’ were used to approximate the patient health history information that is 
commonly captured in GP practice management software.
BMI, body mass index; ED, emergency department; GP, general practice; SES, socioeconomic status. 
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Study. The Sax Institute’s 45 and Up Study is drawn from 
the population of the state of NSW, Australia. Prospec-
tive participants were randomly sampled from the 
Department of Human Services (DHS; formerly Medi-
care Australia) enrolment database, which provides near 
complete coverage of the population. People 80+ years of 
age and residents of rural and remote areas were over-
sampled. A total of 266 942 participants joined the study 
by completing a baseline questionnaire (between January 
2006 and December 2009) and giving signed consent for 
follow-up and linkage of their information to routine 
health databases. With approximately 18% of those 
invited responding, participants represent about 11% of 
the NSW population aged 45 years and older.22
This analysis also incorporated information about 
respondents’ health service use and mortality, obtained 
with patient consent from administrative health data-
bases and linked to their survey responses. This 
included public and private sector hospital separation 
and emergency department (ED) presentation infor-
mation from the NSW admitted patient data collection 
(APDC) and emergency department data collection 
(EDDC). It also included information about subsidised 
GP care from the Medicare Benefits Schedule (MBS) 
and prescription drug use from the Pharmaceuticals 
Benefits Scheme (PBS). Fact of death information was 
obtained from the NSW Registry of Birth Deaths and 
Marriages (RBDM).
The Sax Institute used a unique identifier provided 
by the Australian DHS to link survey responses to the 
MBS and PBS that the DHS provided. Using probabi-
listic methods, the Centre for Health Record Linkage 
conducted the data linkage of APDC, EDDC and RBDM 
data sets.
Cohort definition
We created a NSW cross-sectional, population-based 
cohort (n=263 328) that includes both primary care users 
as well as those with recent hospitalisations, as these are 
common target populations in medical home and inte-
grated care initiatives, including those in Australia.
Prediction outcome and prediction period
The PRM algorithms estimated each respondent’s prob-
ability of experiencing one or more acute emergency 
admissions during Fiscal Year 2009/2010. High-risk 
patients were identified as those in the highest quintile 
(top 20%) of predicted probabilities of hospitalisation. 
Alternative high-risk thresholds, that is, the top 5% or 
10%, were also examined.
Predictor and descriptive variable definitions
A consolidated list of predictor variables was drawn 
from tools in use in the Australian integrated care and 
health care home trials, which included a validated Cana-
dian PRM that uses hospital data only, a UK PRM that 
includes GP data and an Australian-developed clinical 
assessment tool23–26 (see online supplementary appendix 
A). Where data limitations prevented matching measure 
specifications from the three tools, variable definitions 
drew from previous work associating the predictor with 
hospitalisation.27–30 Covariates included self-reported 
measures from the 45 and Up Study (including socio-
demographics, social support, health status, health 
behaviours and functional status) as well as utilisation 
history from the APDC, EDDC and MBS data sets (see 
table 1).
Missing survey responses were included as discrete 
values under the assumption that programmes would likely 
attempt to estimate risk for patients with missing infor-
mation, rather than exclude them from consideration for 
Figure 1 Comparison of high-risk quintiles from the full, GP and hospital scenarios. GP, general practice.
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services. Predictor variables were used as PRM covariates 
and as descriptive variables to characterise the resultant 
high-risk populations. Additional analysis variables iden-
tifying clinical subgroups were created by collapsing or 
combining PRM predictors.
Sociodemographics and social support predictors
Sociodemographic and social support variables (age, 
gender, indigenous status, marital status, language, 
geographic remoteness, socioeconomic status, income 
and social isolation) were obtained from the baseline 
questionnaire. Using birth date, baseline age was updated 
to reflect respondent age during prediction and subse-
quent measurement periods. Quintiles of socioeconomic 
status were derived from residential postcode using the 
Australian Bureau of Statistics (ABS) Index of Relative 
Socioeconomic Disadvantage (Socio-Economic Indexes 
for Areas).31 Similarly, the ABS Accessibility Remoteness 
Index of Australia Plus was used to classify remoteness 
into major city, inner regional, outer regional, remote 
and very remote categories.32 Indigenous status (yes/no) 
included those who self-identified as Aboriginal or Torres 
Strait Islander, or both. Income was based on ‘usual yearly 
household income before tax, from all sources’ and categorised 
into $10 000 increments through $70 000. Social isola-
tion was identified as a response of ‘no one’ to a survey 
question that asked, ‘how many people outside your home, but 
within one hour of travel, do you feel you can depend on or feel 
very close to?’
Health status and health behaviour predictors
To ensure consistency in covariate measurement across the 
three PRM models, all health status and health behaviour 
measures were calculated from the baseline survey even 
when also available in administrative data. Several predic-
tors consisted of risk factor counts. The health condition 
count summed self-reported chronic conditions (0, 1, 2, 
3+) according to participants’ responses to the questions 
‘Has a doctor ever told you that you have…?’ or ‘In the last 
month have you been treated for …?’ The eight conditions 
counted were: heart disease, diabetes, high blood pres-
sure, stroke, blood clots, cancer, asthma or Parkinson’s 
disease. The depression/anxiety measure (yes/no) was 
also derived from these same questions. The polyphar-
macy variable totalled the number of medications (0, 1–4, 
5+) that respondents had ‘taken most of the last 4 weeks’, 
as selected from a list of common medications. The falls 
count (0, 1, 2+) was based on the question, ‘during the past 
12 months, how many times have you fallen to the floor or the 
ground?’
Additional predictors were derived from validated 
items or short standardised scales included in the 45 and 
Up baseline questionnaire. Self-rated health (SF-1) was 
reported as excellent, very good, good, fair or poor. The 
body mass index was collected in kg/m2 and responses 
were classified as underweight (<18.5), normal weight 
(18.6–25), overweight (26–30) and obese (>30). The 
question ‘are you a regular smoker now?’ was used to assess 
baseline smoking status. Alcohol use was estimated from 
self-reports of ‘about how many alcoholic drinks do you have 
each week?’ with unsafe use defined as more than 14 per 
week (adjusted for 9% under-reporting).33 Functional 
capacity was defined according to the Medical Outcomes 
Study, Short Form 36 Physical Functioning Scale scores, 
with no limitation corresponding to a score of (100), 
minor limitation (95–99), mild (85-94), moderate 
(60–84) and severe limitation (0–59).34
Prior hospital/ED utilisation and primary care accessibility
APDC, EDDC and MBS administrative data sets were used 
to calculate prior utilisation predictors. Variable specifica-
tions for the hospitalisation-related covariates were based 
on the Ontario Hospital Admission Risk Prediction. Util-
isation predictors included: acute admission 6 months 
prior (0, 1, 2, 3+), length of stay of prior acute admission 
Figure 2 Intersection of models for different high-risk thresholds.
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(0–2, 3–7, 8–14, 15–30, 31+), admission via ED (yes/
no) and ED visits 6 months prior (0, 1, 2, 3, 4+). GP visits 
in the prior 12 months were also calculated and classified 
as (0, 1–3, 4–5, 6–11, 12+).35 Look-back periods for prior 
hospital, ED and GP service use were calculated from the 
start of the prediction period (1 July 2009).
Population subgroups
Frail elderly were defined as individuals 65+ years that 
reported severe physical limitations and/or two or more 
falls in the last yeari. 36 37 Superutilisers were those with 
2+ acute admissions in the previous 6 months. Fair/
poor health indicates those whose self-rated health was 
fair or poor and multimorbid individuals were those with 
2+ health conditions. Those who died during the predic-
tion year are classified as end of life. Although these 
subpopulations were selected because they are often 
considered clinically distinctive, they are not mutually 
exclusive designations.
PrM modelling scenarios
Three PRM models were developed to simulate high-risk 
population identification within alternative data environ-
ments. These simulations used a combination of service 
use and population survey data to approximate data 
commonly captured through hospital electronic health 
i There is no single generally accepted clinical or operational definition 
of frailty. However, many conceptual frameworks and measures incorpo-
rate older age, poor functional status and a history of falls.
records, GP practice management systems and clinical 
assessment tools.
PRM-1 (‘full model’) was built with comprehensive, 
linked data and used the full, consolidated list of predictor 
variables to define high-risk status. In addition to data 
elements routinely available in GP and hospital settings, 
it included less commonly collected risk factors such as 
income, social isolation and functional status. PRM-2 (‘GP 
model’) simulates a primary care-based implementation. 
Based on the capabilities of the most common practice 
management software in Australia, GPs were assumed to 
have electronic access to sociodemographics, language, 
health/mental health status and health behaviours. 
Conversely, the GP model did not include prior hospi-
talisation, ED or GP visit information because common 
GP practice management software does not track utilisa-
tion history. While practices often have separate business 
software that includes GP visits, only very sophisticated 
practices have the data skills to link business information 
and clinical information for analysis. We did, however, 
conduct sensitivity analyses on our decision to exclude 
past GP use via a GP+ model that included GP utilisation. 
Finally, PRM-3 (‘hospital model’) assumed that primary 
care patient rosters were matched with hospital admin-
istrative data, providing access to patient demographics, 
health status, as well as past hospital and ED use. This data 
matching assumption reflected actual practice in Austra-
lia’s integrated care pilot and ensured consistency in the 
base population across the three PRM test scenarios. (See 
table 1 for model-specific risk predictors.)
Table 2 Variability in case mix among patients identified as ‘high risk’ when varying modelling approach or high-risk 
admission thresholds
Case mix changes: average percentage point spread between 







<5 5–10 >10 <5 5–10 >10
Frail elderly X X
Superutilisers (hospital, ED, GP) X X
Individuals reporting fair/poor health X X
Very old (85+ years) X X
People taking 5+ medications X X
Individuals reporting excellent/very good health X X
Multimorbid individuals X X
Middle-aged adults (45–64 years) X X
People at end of life X X
Unmarried persons X X
Persons with depression/anxiety X X
Sociodemographic groups (men, low income, residents 
of most disadvantaged areas, rural residents non-English 
speakers)
X X
ED, emergency department; GP, general practice.
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All models used a logistic regression to predict the 
outcome of any acute emergency hospitalisation in Fiscal 
Year 2009/2010. The extent to which high-risk individuals 
were admitted to hospital as predicted (positive predic-
tive value) was assessed and the c-statistic was calculated.38 
All statistical analyses were performed in SAS V.9.4 (SAS 
Institute).
descriptive analysis and assessment of persistence
We compared case mix, identification consistency and 
risk persistence among the high-risk populations iden-
tified by each model. High-risk persistence refers to the 
proportion of high-risk individuals who continue to be 
(or reachieve) high-risk status. To assess the persistence, 
we identified individuals in the high-risk quintiles for four 
models. Two GP models were included in this analysis, 
with and without GP utilisation history as a predictor vari-
able. We recalculated the risk quintile of these high-risk 
people on a monthly basis over a 2-year period, applying 
updated age and utilisation risk factor information. All 
other risk predictors were measured at solely baseline, 
so are not time-varying covariates. Individuals who died 
during the prediction period were removed from this 
analysis in the month of their death.
results
Of the 266 942 participants in the 45 and Up Study, 
n=266 519 were eligible for inclusion because they used 
a hospital/ED/medical/pharmacy service between July 
2006 and June 2009. Of these, n=3182 were excluded as 
they died prior to the 1-year prediction period (30 June 
2009). An additional n=9 were excluded for possible 
linkage errors, leaving 263 328 patients for analysis. Char-
acteristics of the full population are provided in online 
supplementary appendix B.
The probability threshold for the high-risk quintiles 
was low for all models (12.0%–13.1%). Approximately 
one-quarter (22.2%–24.9%) of patients in the top risk 
quintile experienced an emergency admission during 
the prediction year (positive predictive value) and these 
high-risk patient admissions represent one-half (48.9%–
54.8%) of total admissions (sensitivity). Statistical perfor-
mance of the three PRM scenarios was very similar, with 
moderately strong c-statistics for all models, ranging from 
0.74 to 0.77.
Despite similarities in predictive accuracy, the three 
PRM scenarios yielded different high-risk individuals 
and population characteristics (figure 1) supplementary 
appendix B.
Sharing three-quarters (74%) of patients in common 
with the full model, the primary care model high-risk 
group includes more multimorbid individuals (62.8% vs 
55.9%) and those in fair/poor health (43.2% vs 39.5%) 
but fewer superutilisers (8.0% vs 13.4%) and those at the 
end of life (3.9% vs 4.4%). The hospital high-risk quin-
tile also agreed with the full model one three-quarters 
of the time (77%). Across the three models, the hospital 
high-risk group includes the lowest proportion of frail 
elderly (34.4% vs 42.3%) and those in fair/poor health 
(27.5% vs 43.2%) and highest proportion of superuti-
lisers (14.3% vs 8.0%). These case mix differences across 
high-risk quintiles are driven by differences among the 
one-quarter of patients not shared in common (see 
figure 1).
Figure 3 Persistence of high-risk group status over time. Per cent of original HR quintiles that are high risk in subsequent 24 
months. GP, general practice; HR, high risk.
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Nearly two-thirds (59%) of the top quintile of high-risk 
individuals were consistently identified within all three 
models (see Figure 2). As compared with the full model, 
this overlap group has higher morbidity and mortality: 
with multimorbid individuals (69.6% vs 55.9%), frail 
elderly (50.1% vs 42.3%) in fair/poor health (42.7% vs 
39.5%) and very old (31.4% vs 18.7%). They are also 
somewhat more likely to be at the end of life (5.7% vs 
4.4%). As the high-risk threshold is increased to the 90th 
or 95th decile, positive predictive values increase in the 
range of 28.3–33.5 and 34.3–41.8, respectively, but the 
models’ intersection decreases, falling to 48% and 39% 
shared patients, respectively. This results primarily from 
the GP model diverging from the other two (online 
supplementary appendix B).
Table 2 summarises the extent to which characteris-
tics of the high-risk patient cohort changed when using 
different models or risk prediction thresholds. High-risk 
group acuity increased dramatically as high-risk thresh-
olds increased. Proportions of very old, frail elderly, 
multimorbid individuals, superutilisers and those who 
report fair/poor health increased by more than 10 
percentage points. With the exception of age and marital 
status, there was little change (<5 percentage points) in 
the sociodemographic and behavioural profile of high-
risk patients, irrespective of model or high-risk threshold. 
Although not all population characteristics were explic-
itly measured in all models (table 1), this did not consis-
tently affect their prevalence in high-risk groups. For 
example, functional status was measured explicitly only 
in the full model, but individuals with severe functional 
limitations accounted for at least one-third of high-
risk quintile patients (32.3%–45.5%) across models. In 
general, patient characteristics with high ORs (>1.3) 
were the most sensitive to modelling specifications. (See 
online supplementary appendix C for ORs and online 
supplementary appendix B for selected case-mix charac-
teristics by model and threshold).
Figure 3 illustrates that four in five (78.8%) high-risk 
individuals for the full model and three of four (74.3%) 
in the hospital model remain persistently high risk when 
re-evaluated over a 2-year period. For these models, 
approximately 20%–25% of high-risk group members 
gradually lose high-risk status throughout the first year 
following identification. High-risk group membership 
stabilises thereafter.
Reduction in risk status results from individuals no 
longer meeting the ‘prior ED’ or ‘prior hospitalisation’ 
criteria, which are used to assess risk in the full and 
hospital models. By contrast, all of the GP high-risk quin-
tiles (100%) remained persistently high risk, because only 
age changed over the 2-year period. Unlike the other two 
models, the GP model did not include utilisation history, 
and all other risk factors were measured solely at base-
line. While advancing age increases risk status, this anal-
ysis focuses on individuals already at highest risk. As a 
result, for a fixed survey cohort, high-risk status did not 
vary over time. In the GP+ model that included GP usage 
history, 12.9% of high-risk individuals identified with the 
GP+ model lost high-risk status over 2 years.
dIsCussIOn
To effectively leverage PRM as part of the implementa-
tion of medical home, integrated care and other quality 
improvement efforts, stakeholders need to know whether 
they are targeting the ‘right’ patients and to understand 
how well health systems are currently performing for 
them. Who is the ‘right’ patient depends on the clinical 
or measurement context. Our study demonstrated sensi-
tivity of case mix and risk persistence to PRM specifica-
tions, resulting in somewhat different target populations 
with different hospitalisation risks. One cannot rely solely 
on predictive performance to assess model suitability for 
either clinical or evaluative purposes.
Among our population-based cohort, all three models 
resulted in high-risk quintiles that included relatively low 
cut points for the risk of admission (12%–13%), with one 
in four individuals subsequently hospitalised. The large 
number of people with lower risk scores meant that the 
high-risk population was sensitive to varying risk predic-
tors and thresholds. As high-risk thresholds increased, 
case mix was increasingly characterised by high propor-
tions of very old, frail elderly, multimorbid individuals, 
and those who report fair/poor health. At the 95th 
percentile, for example, more than one in four high-risk 
group members had a history of repeat hospitalisations 
and nearly 1 in 10 would die during the prediction year. 
Differences between high-risk groups reflected the stron-
gest PRM predictors, highlighting the need to ensure 
the modelling specifications are optimised to ‘find cases’ 
appropriate for the intervention.
Risk status may be conceptualised as something that 
changes over time (eg, as an outcome) or it may be 
thought of as a relatively stable characteristic of a patient 
or a population. How long a person remained high risk 
depended on the PRM’s relative reliance on factors that 
could change over time—only age and recent utilisation 
history in our models. Risk status was least stable in PRMs 
that incorporated prior hospital use. It is common in 
clinical settings to have access to both time-variant and 
time-invariant patient data. Some patient information 
is regularly updated (eg, utilisation history, age). Other 
patient data do not typically change (gender, race/
ethnicity). Still other information may be collected once 
for a specific purpose or infrequently reassessed (eg, eligi-
bility screening data).
Case-finding implications
Case-finding PRM applications seek to target interven-
tions by identifying patients at risk of hospitalisation. 
Our results demonstrate that fully or partially linked 
data identified high-risk patients who would not have 
been classified as such using GP data alone—for 
example, superutilisers with multiple prior hospitalisa-
tions. In a GP setting, such patients may not have been 
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targeted for closer monitoring, especially if they were 
out of care or new to the practice. Sharing actionable 
information across data settings clearly improves case-
finding potential and is often an explicit motivation for 
PRM.
Whether a patient’s high-risk status is relatively more 
persistent or episodic also has bearing on case-finding. 
For example, if risk manifests episodically, clinical inter-
ventions may be short term and time sensitive. To iden-
tify new at-risk patients in near real time, the PRM base 
population may need to be updated and reassessed more 
frequently. In practice, not all variables commonly used 
in PRMs are available on a real-time basis, including 
those (eg, hospitalisation history) that influence risk 
persistence.8 If data lags are long, the window of opportu-
nity for intervention may close before providers become 
aware of a change in risk status.
Performance measurement implications
Additional considerations apply for the use of PRM in 
performance measurement applications. Here, the aim is 
to define high-risk population segments, for example, to 
understand how well health systems have been performing 
for high-risk populations and evaluate the impact of new 
models of care. PRM-defined population segments could 
be used to describe the regional distribution of high-
risk populations and to assess past and current service 
use, morbidity, mortality and other medical home/inte-
grated care outcomes. Fair and appropriate performance 
measurement therefore requires a reasonable match 
between target populations identified via case-finding and 
corresponding performance measurement populations. 
Yet in our findings, only three-quarters of patients, at best, 
were commonly identified using data available in different 
settings. While the minimum degree of agreement neces-
sary for analysis may differ across performance measure-
ment applications—for example, programme evaluation 
may differ from ongoing health system reporting—it is 
clear that clinical intervention and performance popu-
lations will not be fully equivalent unless they are using 
exactly the same data.
Even with identical data, pragmatic data analysis deci-
sions could inadvertently introduce bias. For example, 
case-finding applications often set risk thresholds high 
due to clinical capacity constraints,39 while performance 
measurement applications may prefer larger risk groups 
to ensure adequate sample size for analysis. In our simu-
lation, morbidity and mortality dramatically increased 
as risk thresholds increased. Therefore, creating a 
larger analysis population by relaxing the PRM high-risk 
threshold would increase sample size (intended) and 
change case mix (unintended).
Stratified approaches to performance measurement 
also need to reflect on the persistence of high-risk status 
relative to the outcome assessment time frame. Stratified 
analysis is well suited for short-term outcomes that are 
measured soon after patients are classified as high risk, 
such as care planning or readmission. However, medical 
home and integrated care initiatives often aim to reduce 
long-term hospitalisation rates and costs, measured years 
later.40 In our simulation, up to 20% of high-risk patients 
in the full model and 25% identified via the hospital 
model would change risk status within a year of identifica-
tion. From a performance measurement perspective, this 
means that high-risk patients who become lower risk over 
time—whether due to usual care or programme interven-
tions—would no longer be counted among the ‘high-risk’ 
strata for which outcomes are reported, unless method-
ological steps were employed to retain them.
Theoretically, variation in care could also be reflected in 
risk status, and persistence of high-risk status could poten-
tially be explored as an outcome of care to be assessed 
as part of performance measurement. The GP model, 
with regularly updated risk factor information related 
to health behaviours and self-rated health, might work 
well for this purpose. By contrast, the hospital model is 
highly endogenous, with recent hospitalisation history a 
key determinant in establishing current (hospitalisation) 
risk status. Because risk scores in this instance track with 
recent hospital use, monitoring hospitalisation patterns 
may provide a more direct means for benchmarking and 
evaluating variation in care. Given the predominantly 
time-invariant variables in our study, we did not attempt 
to investigate the utility of risk status persistence as an 
outcome but highlight it as a promising area for future 
research.
Regional differences may emerge in stratified 
performance outcomes or in high-risk patients’ rates 
of return to lower risk status. Designing meaningful 
comparisons of performance across sites will require 
careful consideration. Within the broader high-risk 
population segment, case mix is likely to differ by clin-
ical site, especially if they implement PRMs tailored to 
their populations. Even with a standard PRM, known 
regional variations in demographics and health status 
will likely result in some sites having high-risk groups 
dominated by frail elderly, others by superutilisers and 
still others by the multimorbid. For certain perfor-
mance comparisons, it may be necessary to risk-adjust 
(within risk strata) or further stratify (eg, by subgroup) 
to account for this heterogeneity. This area is also ripe 
for additional research.
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